目的 分析一对经典型枫糖尿病（MSUD）汉族双胎新生儿的临床特点及其相关基因的致病性突变，为MSUD早期诊治提供指导。方法 收集患儿的临床及影像学资料，提取患儿及其父母的外周血，检测枫糖尿病相关基因（BCKDHA，BCKDHB，DBT，DLD），确定基因突变位点，并进行生物信息学分析。结果 双胎患儿在BCKDHB基因上发现2个突变：错义突变c.304G > A（p.Gly102Arg）和无义突变c.331C > T（p.Arg111*），均为杂合子，且c.304G > A（p.Gly102Arg）为国际上未报道的新突变。其父亲携带错义突变c.304G > A（p.Gly102Arg），其母亲携带无义突变c.331C > T（p.Arg111*）。结论 BCKDHB基因c.331C > T（p.Arg111*）杂合突变是该双胎患儿的致病性突变，是枫糖尿病患儿临床表现的基因分子基础。
Abstract
Objective To investigate the clinical features of one pair of twin neonates with maple syrup urine disease (MSUD) in the Chinese Han population and pathogenic mutations in related genes, and to provide guidance for the early diagnosis and treatment of MSUD. Methods The clinical and imaging data of the twin neonates were collected. The peripheral blood samples were collected from the twin neonates and their parents to detect the genes related to MSUD (BCKDHA, BCKDHB, DBT, and DLD). The loci with gene mutations were identified, and a bioinformatic analysis was performed. Results Two mutations were detected in the BCKDHB gene, missense mutation c.304G > A (p.Gly102Arg) and nonsense mutation c.331C > T (p.Arg111*), and both of them were heterozygotes. The mutation c.304G > A (p.Gly102Arg) had not been reported in the world. Their father carried the missense mutation c.304G > A (p.Gly102Arg), and their mother carried the nonsense mutation c.331C > T (p.Arg111*). Conclusions The c.331C > T (p.Arg111*) heterozygous mutation in BCKDHB gene is the pathogenic mutation in these twin neonates and provides a genetic and molecular basis for the clinical features of children with MSUD.
关键词
枫糖尿病 /
双胎 /
基因突变 /
新生儿
Key words
Maple syrup urine disease /
Twin pregnancy /
Gene mutation /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Menkes JH, Horst PL, Craig JM. A new syndrome:progressive familial infantile cerebral dysfunction associated with an unusual urinary substance[J]. Pediatrics, 1954, 14(5):462-467.
[2] Strauss KA, Mazariegos GV, Sindhi R. Elective liver transplantation for the treatment of classical maple syrup urine disease[J]. Am J Transplant, 2006, 6(3):557-564.
[3] 沈云琳, 龚小慧, 颜景斌, 等. 新生儿枫糖尿病一例及其基因突变分析[J]. 中华儿科杂志, 2015, 53(1):66-70.
[4] Sato T, Muroya K, Hanakawa J, et al. Neonatal case of classic maple syrup urine disease:Usefulness of 1H-MRS in early diagnosis[J]. Pediatr Int, 2014, 56(1):112-115.
[5] Lavin LR, Higby N, Abramo T. Newborn screening:What does the emergency physician need to know[J]. Pediatr Emerg Care, 2015, 31(9):661-667.
[6] Burrage LC, Nagamani SC, Campeau PM, et al. Branched-chain amino acid metabolism:from rare Mendelian diseases to more common disorders[J]. Hum Mol Genet, 2014, 23(R1):R1-8.
[7] Alodaib A, Carpenter K, Wiley V, et al. An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples[J]. Ann Clin Biochem, 2011, 48(Pt5):468-470.
[8] Skvorak KJ. Animal models of maple syrup urine disease[J]. J Inherit Metab Dis, 2009, 32(2):229-246.
[9] Mitsubuchi H, Nobukuni Y, Hayashida Y, et al. Gene analysis of maple syrup urine disease(MSUD)[J]. Rinsho Byori, 1993, 41(5):484-491.
[10] Fernández-Guerra P, Navarrete R, Weisiger K, et al. Functional characterization of the novel intronic nucleotide change c.288+9C>T within the BCKDHA gene:understanding a variant presentation of maple syrup urine disease[J]. J Inherit Metab Dis, 2010, 33(Suppl 3):S191-198.
[11] Puffenberger EG. Genetic heritage of the old order mennonites of southeastern Pennsylvania[J]. Am J Med Genet C Semin Med Genet, 2003, 121C(1):18-31.
[12] Scaini G, Jeremias IC, Morais MO, et al. DNA damage in an animal model of maple syrup urine disease[J]. Mol Genet Metab, 2012, 106(2):169-174.
[13] Flaschker N, Feyen O, Fend S, et al. Description of the mutations in 15 subjects with variant forms of maple syrup urine disease[J]. J Inherit Metab Dis, 2007, 30(6):903-909.
[14] 蒋丰智, 崔其亮, 江剑辉. 家族性枫糖尿病1例临床诊治体会[J]. 中国当代儿科杂志, 2009, 11(7):599-600.
[15] Páez Rojas PL, Suarez Obando F. Genetic and metabolic urgencies in the neonatal intensive care unit:maple syrup urine disease[J]. Nutr Hosp, 2015, 32(1):420-425.
[16] Simon E, Wendel U, Schadewaldt P. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany[J]. Turk J Pediatr, 2005, 47(1):8-13.
[17] Skvorak KJ, Paul HS, Dorko K, et al. Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease[J]. Mol Ther, 2009, 17(7):1266-1273.
PDF(1484 KB)
